1. Home
  2. MPLN vs MGTX Comparison

MPLN vs MGTX Comparison

Compare MPLN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPLN
  • MGTX
  • Stock Information
  • Founded
  • MPLN 1980
  • MGTX 2015
  • Country
  • MPLN United States
  • MGTX United States
  • Employees
  • MPLN N/A
  • MGTX N/A
  • Industry
  • MPLN Business Services
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MPLN Consumer Discretionary
  • MGTX Health Care
  • Exchange
  • MPLN Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • MPLN 302.9M
  • MGTX 282.3M
  • IPO Year
  • MPLN N/A
  • MGTX N/A
  • Fundamental
  • Price
  • MPLN $0.38
  • MGTX $4.60
  • Analyst Decision
  • MPLN Hold
  • MGTX Strong Buy
  • Analyst Count
  • MPLN 1
  • MGTX 2
  • Target Price
  • MPLN $2.00
  • MGTX $26.00
  • AVG Volume (30 Days)
  • MPLN 5.7M
  • MGTX 208.8K
  • Earning Date
  • MPLN 08-01-2024
  • MGTX 08-08-2024
  • Dividend Yield
  • MPLN N/A
  • MGTX N/A
  • EPS Growth
  • MPLN N/A
  • MGTX N/A
  • EPS
  • MPLN N/A
  • MGTX N/A
  • Revenue
  • MPLN $959,438,000.00
  • MGTX $697,000.00
  • Revenue This Year
  • MPLN $7.02
  • MGTX N/A
  • Revenue Next Year
  • MPLN $6.32
  • MGTX $447.29
  • P/E Ratio
  • MPLN N/A
  • MGTX N/A
  • Revenue Growth
  • MPLN N/A
  • MGTX N/A
  • 52 Week Low
  • MPLN $0.26
  • MGTX $3.49
  • 52 Week High
  • MPLN $2.16
  • MGTX $7.60
  • Technical
  • Relative Strength Index (RSI)
  • MPLN 48.64
  • MGTX 56.56
  • Support Level
  • MPLN $0.26
  • MGTX $3.97
  • Resistance Level
  • MPLN $0.33
  • MGTX $4.20
  • Average True Range (ATR)
  • MPLN 0.05
  • MGTX 0.22
  • MACD
  • MPLN 0.01
  • MGTX 0.08
  • Stochastic Oscillator
  • MPLN 59.95
  • MGTX 80.94

About MPLN MultiPlan Corporation

MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: